MK-0677

DRUG2 trials

Sponsors

University of Virginia

Conditions

Chronic Kidney DiseaseEnd Stage Renal DiseaseKidney Disease

Phase 2

Growth Hormone Secretagogue MK-0677's Effect on Lean Body Mass in Chronic Kidney Disease Stage 4/5 Subjects

WithdrawnNCT01343641

University of VirginiaChronic Kidney Disease, Kidney Disease

Start: 2009-03-31End: 2010-04-30Updated: 2018-05-14

Unknown Phase

Growth Hormone Secretagogue MK-0677 Effect on IGF-1 Levels in ESRD Patients

CompletedNCT00395291

University of VirginiaChronic Kidney Disease, End Stage Renal Disease

Start: 2006-08-31End: 2010-05-31Updated: 2017-02-20